Scientists found that leukemic stem cells in chronic myelomonocytic leukemia resided in a CD34+/CD38− fraction of the malignant clone.
[Leukemia]
6445212 {6445212:WYPHSZL3} apa 50 1 160865 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-5d728271e910d35622a0365cae0d3494%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22WYPHSZL3%22%2C%22library%22%3A%7B%22id%22%3A6445212%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Eisenwort%20et%20al.%22%2C%22parsedDate%22%3A%222021-03-30%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EEisenwort%2C%20G.%2C%20Sadovnik%2C%20I.%2C%20Keller%2C%20A.%2C%20Ivanov%2C%20D.%2C%20Peter%2C%20B.%2C%20Berger%2C%20D.%2C%20Stefanzl%2C%20G.%2C%20Bauer%2C%20K.%2C%20Slavnitsch%2C%20K.%2C%20Greiner%2C%20G.%2C%20Gleixner%2C%20K.%20V.%2C%20Sperr%2C%20W.%20R.%2C%20Willmann%2C%20M.%2C%20Sill%2C%20H.%2C%20Bettelheim%2C%20P.%2C%20Geissler%2C%20K.%2C%20Deininger%2C%20M.%2C%20R%26%23xFC%3Blicke%2C%20T.%2C%20%26amp%3B%20Valent%2C%20P.%20%282021%29.%20Phenotypic%20characterization%20of%20leukemia-initiating%20stem%20cells%20in%20chronic%20myelomonocytic%20leukemia.%20%3Ci%3ELeukemia%3C%5C%2Fi%3E%2C%201%26%23x2013%3B12.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41375-021-01227-z%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41375-021-01227-z%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445212%26amp%3Bitem_key%3DWYPHSZL3%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Phenotypic%20characterization%20of%20leukemia-initiating%20stem%20cells%20in%20chronic%20myelomonocytic%20leukemia%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregor%22%2C%22lastName%22%3A%22Eisenwort%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Irina%22%2C%22lastName%22%3A%22Sadovnik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Keller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Ivanov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Barbara%22%2C%22lastName%22%3A%22Peter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniela%22%2C%22lastName%22%3A%22Berger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriele%22%2C%22lastName%22%3A%22Stefanzl%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karin%22%2C%22lastName%22%3A%22Bauer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katharina%22%2C%22lastName%22%3A%22Slavnitsch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Georg%22%2C%22lastName%22%3A%22Greiner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karoline%20V.%22%2C%22lastName%22%3A%22Gleixner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wolfgang%20R.%22%2C%22lastName%22%3A%22Sperr%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Willmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heinz%22%2C%22lastName%22%3A%22Sill%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Bettelheim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Klaus%22%2C%22lastName%22%3A%22Geissler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Deininger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22R%5Cu00fclicke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Valent%22%7D%5D%2C%22abstractNote%22%3A%22Chronic%20myelomonocytic%20leukemia%20%28CMML%29%20is%20a%20stem%20cell-derived%20neoplasm%20characterized%20by%20dysplasia%2C%20uncontrolled%20expansion%20of%20monocytes%2C%20and%20substantial%20risk%20to%20transform%20to%20secondary%20acute%20myeloid%20leukemia%20%28sAML%29.%20So%20far%2C%20little%20is%20known%20about%20CMML-initiating%20cells.%20We%20found%20that%20leukemic%20stem%20cells%20%28LSC%29%20in%20CMML%20reside%20in%20a%20CD34%2B%5C%2FCD38%5Cu2212%20fraction%20of%20the%20malignant%20clone.%20Whereas%20CD34%2B%5C%2FCD38%5Cu2212%20cells%20engrafted%20NSGS%20mice%20with%20overt%20CMML%2C%20no%20CMML%20was%20produced%20by%20CD34%2B%5C%2FCD38%2B%20progenitors%20or%20the%20bulk%20of%20CD34%5Cu2212%20monocytes.%20CMML%20LSC%20invariably%20expressed%20CD33%2C%20CD117%2C%20CD123%20and%20CD133.%20In%20a%20subset%20of%20patients%2C%20CMML%20LSC%20also%20displayed%20CD52%2C%20IL-1RAP%20and%5C%2For%20CLL-1.%20CMML%20LSC%20did%20not%20express%20CD25%20or%20CD26.%20However%2C%20in%20sAML%20following%20CMML%2C%20the%20LSC%20also%20expressed%20CD25%20and%20high%20levels%20of%20CD114%2C%20CD123%20and%20IL-1RAP.%20No%20correlations%20between%20LSC%20phenotypes%2C%20CMML-variant%2C%20mutation-profiles%2C%20or%20clinical%20course%20were%20identified.%20Pre-incubation%20of%20CMML%20LSC%20with%20gemtuzumab-ozogamicin%20or%20venetoclax%20resulted%20in%20decreased%20growth%20and%20impaired%20engraftment%20in%20NSGS%20mice.%20Together%2C%20CMML%20LSC%20are%20CD34%2B%5C%2FCD38%5Cu2212%20cells%20that%20express%20a%20distinct%20profile%20of%20surface%20markers%20and%20target-antigens.%20During%20progression%20to%20sAML%2C%20LSC%20acquire%20or%20upregulate%20certain%20cytokine%20receptors%2C%20including%20CD25%2C%20CD114%20and%20CD123.%20Characterization%20of%20CMML%20LSC%20should%20facilitate%20their%20enrichment%20and%20the%20development%20of%20LSC-eradicating%20therapies.%22%2C%22date%22%3A%222021-03-30%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41375-021-01227-z%22%2C%22ISSN%22%3A%221476-5551%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41375-021-01227-z%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-04-06T20%3A28%3A15Z%22%7D%7D%5D%7D
Eisenwort, G., Sadovnik, I., Keller, A., Ivanov, D., Peter, B., Berger, D., Stefanzl, G., Bauer, K., Slavnitsch, K., Greiner, G., Gleixner, K. V., Sperr, W. R., Willmann, M., Sill, H., Bettelheim, P., Geissler, K., Deininger, M., Rülicke, T., & Valent, P. (2021). Phenotypic characterization of leukemia-initiating stem cells in chronic myelomonocytic leukemia. Leukemia, 1–12. https://doi.org/10.1038/s41375-021-01227-z Cite